With the explosion of genomic technology, numerous studies have demonstrated
the potential clinical utility of gene expression profiles as a predictor of prog-
nosis and response to therapy. Of particular interest is the demonstration that
there is a general link between poor prognostic features and response to che-
motherapy. In addition, linearity of RNA-based assays shows a strong promise
that they can be very useful as predictive assays for targeted therapies.